Table 4.
Hormone replacement therapy in the postoperative period
| Function | Medicine | Manufacturer | Period | Dose / administration method |
|---|---|---|---|---|
| Antidiuretic hormone | Desmopressin acetate | Kissei Pharmaceutical CO., LTD | Immediately after TSS to 5 days after TSS | 0.1 μg/kg, sc, bid |
| Desmopressin acetate | Kissei Pharmaceutical CO., LTD | 6 days after TSS to present | 0.1 μg/kg, os, bid | |
| Adrenocortical hormone | Hydrocortisone | Nichi-Iko Pharmaceutical CO., LTD | Immediately after TSS to 1 day after TSS | 1.0 mg/kg, iv, qid |
| Prednisolone | Yoshindo Co., Ltd. | 2 days after TSS to present | 0.1–0.2 mg/kg, po, bid | |
| Thyroid hormone | Levothyroxine sodium | ASKA Pharmaceutical CO., LTD. | 7 days before TSS to present | 20–30 μg/kg, po, bid |
| Estrogenic hormone · | Ethinylestradiol | ASKA Pharmaceutical CO., LTD. | 62 days after TSS to present | 0.03 mg/kg, po, sid |
TSS Trans-sphenoidal surgery